AIMS: To assess the predictive value of fasting and 2-h glucose after a 75 g glucose load, with regard to incidence of coronary heart disease and cardiovascular mortality. METHODS AND RESULTS: 6766 subjects from five Finnish cohorts aged 30-89 years were followed up for 7-10 years. Hazards ratios associated with increasing glucose concentrations were homogeneous over studies. Multivariate Cox regression analyses showed that the hazards ratio for one standard deviation increase in 2-h glucose after logarithmic transformation was 1.17 (95% CI 1.05-1.30) for coronary heart disease incidence and 1.22 (1.09-1.37) for cardiovascular mortality. For fasting glucose, they were 1.05 (0.94-1.17) and 1.13 (1.01-1.25), respectively. Inclusion of 2-h glucose in the model based on fasting glucose significantly improved the prediction (P<0.005 for coronary heart disease incidence and P<0.025 for cardiovascular mortality), whereas fasting glucose did not add significant information to the model initially based on 2-h glucose (P>0.10 for both events). CONCLUSION: In subjects without a prior history of diabetes the association of 2-h glucose with coronary heart disease incidence and cardiovascular morality is graded and independent. The results of our study indicate that 2-h glucose is superior to fasting glucose in assessing the risk of future cardiovascular disease events. Copyright 2002 The European Society of Cardiology Published by Elsevier Science Ltd.
AIMS: To assess the predictive value of fasting and 2-h glucose after a 75 g glucose load, with regard to incidence of coronary heart disease and cardiovascular mortality. METHODS AND RESULTS: 6766 subjects from five Finnish cohorts aged 30-89 years were followed up for 7-10 years. Hazards ratios associated with increasing glucose concentrations were homogeneous over studies. Multivariate Cox regression analyses showed that the hazards ratio for one standard deviation increase in 2-h glucose after logarithmic transformation was 1.17 (95% CI 1.05-1.30) for coronary heart disease incidence and 1.22 (1.09-1.37) for cardiovascular mortality. For fasting glucose, they were 1.05 (0.94-1.17) and 1.13 (1.01-1.25), respectively. Inclusion of 2-h glucose in the model based on fasting glucose significantly improved the prediction (P<0.005 for coronary heart disease incidence and P<0.025 for cardiovascular mortality), whereas fasting glucose did not add significant information to the model initially based on 2-h glucose (P>0.10 for both events). CONCLUSION: In subjects without a prior history of diabetes the association of 2-h glucose with coronary heart disease incidence and cardiovascular morality is graded and independent. The results of our study indicate that 2-h glucose is superior to fasting glucose in assessing the risk of future cardiovascular disease events. Copyright 2002 The European Society of Cardiology Published by Elsevier Science Ltd.
Authors: Dan Ziegler; Andreas Voss; Wolfgang Rathmann; Alexander Strom; Siegfried Perz; Michael Roden; Annette Peters; Christa Meisinger Journal: Diabetologia Date: 2015-02-28 Impact factor: 10.122
Authors: Michelle A Van Name; Anne W Camp; Elizabeth A Magenheimer; Fangyong Li; James D Dziura; Abmaridel Montosa; Anisha Patel; William V Tamborlane Journal: Diabetes Care Date: 2016-02-23 Impact factor: 19.112
Authors: Katherine A Pratte; Ann Johnson; Janette Beals; Ann Bullock; Spero M Manson; Luohua Jiang Journal: Diabetes Care Date: 2019-06-08 Impact factor: 19.112
Authors: Cees J Tack; Vladimir Christov; Bastiaan E de Galan; Karl-Michael Derwahl; Gerhard Klausmann; Terezie Pelikánová; Jindra Perusicová; Anders H Boss; Nikhil Amin; David Kramer; Richard Petrucci; Wen Yu Journal: J Diabetes Sci Technol Date: 2008-01